EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Country‐Level RSV‐Related Hospitalisation Rates Among Adults in High‐Income Countries From an Ensemble Model Based on Direct Viral Testing Incidence Data

Shuyu Deng, Tiantian Zhang, Yihua Xu, Elizabeth Begier, Caihua Liang iD, Reiko Sato, Sebastien Kenmoe iD, Bradford D Gessner, Harish Nair iD, You Li

Influenza and Other Respiratory Viruses · 2026-07 · 20 (7)

DOI: 10.1111/irv.70291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, online erschienen am 09.07.2026. Verfasst von Shuyu Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Hospitalization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Understanding hospitalisation burden of respiratory syncytial virus (RSV)–associated acute respiratory infection (ARI) in adults is crucial for informing immunisation policy, yet such data are lacking in most high‐income countries. We aimed to estimate country‐level RSV‐associated ARI hospitalisation rates among adults aged 18–64 and ≥ 65 years across high‐income countries.

Methods

Data on adult RSV hospitalisation burden were identified from systematic literature review and national surveillance reports. A Bayesian adjustment was applied to account for underascertainment due to variability in diagnostic methods and clinical specimens. An ensemble modelling framework consisting of four independent approaches was developed to predict country‐level RSV‐associated ARI hospitalisation rates among adults aged 18–64 and ≥ 65 years across 63 high‐income countries.

Results

The ensemble model predicted a median annual RSV‐associated ARI hospitalisation rate of 39 per 100,000 (interquartile range [IQR]: 33–48) for adults aged 18–64 years and 374 per 100,000 (318–468) for those aged ≥ 65 years across the 63 countries. The predicted rates varied substantially by continent; Africa (Seychelles) had the lowest RSV hospitalisation rate for both 18–64 and ≥ 65 years (17 and 188 per 100,000, respectively); the highest median RSV hospitalisation rate was in Oceania in adults aged 18–64 years (50 per 100,000; IQR: 31–51) and was in the Americas in adults aged ≥ 65 years (455 per 100,000; 428–518). Europe and Asia showed marked within‐continent variations in RSV hospitalisation rates.

Conclusions

Although primary RSV disease burden data remain the gold standard for evidence‐based vaccine policy development, this study offers a viable alternative reference for high‐income countries lacking such data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsHospitalizationHumansAdultMiddle AgedAdolescentYoung AdultIncidenceAgedDeveloped CountriesRespiratory Syncytial Virus, HumanFemale

Stichwörter der Autor:innen

adultdisease burdenhospitalisationpredictionrespiratory syncytial virusunderascertainmentvaccine

Autor:innen und Institutionen

  • Department of Epidemiology, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Key Laboratory of Public Health Safety and Emergency Prevention and Control Technology of Higher Education Institutions in Jiangsu Province, Nanjing Medical University, Nanjing, China.
  • Global Medical Development Scientific and Clinical Affairs, Pfizer Vaccines, Dublin, Ireland.
  • Global Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA.
  • HTA Value & Evidence, Pfizer Inc, Collegeville, Pennsylvania, USA.
  • Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK.

ORCID-Profile: Caihua Liang, Sebastien Kenmoe, Harish Nair

Förderung

  • Pfizer

Zitieren

APA

Deng, S., Zhang, T., Xu, Y., Begier, E., Liang, C., Sato, R., Kenmoe, S., Gessner, B. D., Nair, H., & Li, Y. (2026). Country‐Level RSV‐Related Hospitalisation Rates Among Adults in High‐Income Countries From an Ensemble Model Based on Direct Viral Testing Incidence Data. Influenza and Other Respiratory Viruses, 20(7). https://doi.org/10.1111/irv.70291

Vancouver

Deng S, Zhang T, Xu Y, Begier E, Liang C, Sato R, et al. Country‐Level RSV‐Related Hospitalisation Rates Among Adults in High‐Income Countries From an Ensemble Model Based on Direct Viral Testing Incidence Data. Influenza and Other Respiratory Viruses. 2026;20(7). doi:10.1111/irv.70291

BibTeX
@article{Deng2026,
  author = {Deng, Shuyu and Zhang, Tiantian and Xu, Yihua and Begier, Elizabeth and Liang, Caihua and Sato, Reiko and Kenmoe, Sebastien and Gessner, Bradford D and Nair, Harish and Li, You},
  title = {Country‐Level RSV‐Related Hospitalisation Rates Among Adults in High‐Income Countries From an Ensemble Model Based on Direct Viral Testing Incidence Data},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2026},
  volume = {20},
  number = {7},
  doi = {10.1111/irv.70291}
}
Kostenlos starten →